SEC Form 4 · accession 0000884905-15-000028
PRAXAIR INC · PX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen F Angel
Officer — Chairman, President & CEO · Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884905
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | M | 40,786 | $53.98 | A | 142,096 | D | |
| Common StockF1 | Feb 27, 2015 | S | 40,786 | $128.19 | D | 101,310 | D | |
| Common Stock | Mar 2, 2015 | M | 16,242 | $53.98 | A | 117,552 | D | |
| Common StockF2 | Mar 2, 2015 | S | 16,242 | $129.20 | D | 101,310 | D | |
| Common Stock | Mar 2, 2015 | M | 125,000 | $61.47 | A | 226,310 | D | |
| Common StockF3 | Mar 2, 2015 | S | 125,000 | $129.38 | D | 101,310 | D | |
| Common Stock | holding | — | — | — | 2,268 | I | In trust for children | |
| Common Stock | holding | — | — | — | 58,065 | I | Grantor Retained Annuity Trusts | |
| Common Stock | holding | — | — | — | 7,879 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $53.98 | Feb 27, 2015 | M | 40,786 | D | Feb 28, 2007 | Feb 29, 2016 | Common Stock | 40,786 | 16,242 | D |
| Stock Option (right t buy)F4 | $53.98 | Mar 2, 2015 | M | 16,242 | D | Feb 28, 2007 | Feb 29, 2016 | Common Stock | 16,242 | 0 | D |
| Stock Option (right to buy)F4 | $61.47 | Mar 2, 2015 | M | 125,000 | D | Feb 27, 2008 | Feb 27, 2017 | Common Stock | 125,000 | 183,300 | D |
| Stock Option (right to buy)F4 | $83.89 | holding | — | — | — | Feb 26, 2009 | Feb 26, 2018 | Common Stock | 195,200 | 195,200 | D |
| Stock Option (right to buy)F4 | $60.92 | holding | — | — | — | Feb 24, 2010 | Feb 24, 2019 | Common Stock | 281,510 | 281,510 | D |
| Stock Option (right to buy)F4 | $76.16 | holding | — | — | — | Feb 23, 2011 | Feb 23, 2020 | Common Stock | 204,640 | 204,640 | D |
| Stock Option (right to buy)F4 | $97.84 | holding | — | — | — | Feb 22, 2012 | Feb 22, 2021 | Common Stock | 218,175 | 218,175 | D |
| Stock Option (right to buy)F5 | $109.68 | holding | — | — | — | Feb 28, 2013 | Feb 28, 2022 | Common Stock | 236,510 | 236,510 | D |
| Stock Option (right to buy)F6 | $110.58 | holding | — | — | — | Feb 26, 2014 | Feb 26, 2023 | Common Stock | 187,015 | 187,015 | D |
| Stock Option (right to buy)F7 | $128.80 | holding | — | — | — | Feb 25, 2015 | Feb 25, 2024 | Common Stock | 203,930 | 203,930 | D |
| Stock Option (right to buy)F8 | $128.38 | holding | — | — | — | Feb 24, 2016 | Feb 24, 2025 | Common Stock | 261,075 | 261,075 | D |
| Deferred Stock UnitF9,F10 | $0.00 | holding | — | — | — | — | — | Common Stock | 61,187 | 61,187 | D |
Explanation of responses
- F1The $128.19 price reported is the weighted average sale price. The sale prices ranged from $128.000 to $128.620 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- F10Deferred stock units acquired under the Praxair Compensation Deferral Program as amended and are to be settled in Praxair Common Stock.
- F2The $129.20 price reported is the weighted average sale price. The sale prices ranged from $129.050 to $129.310 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- F3The $129.38 price reported is the weighted average sale price. The sale prices ranged from $129.045 to $130.37 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- F4This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- F5This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- F6This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
- F7This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
- F8This option vests over three years in three consecutive equal annual installments beginning on February 24, 2016.
- F9Conversion to Praxair Common Stock is on a 1-for-1 basis.